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Abstract
Background: The aim of this study was to evaluate the rate of periocular allergic skin reactions to topical
neomycin, polymyxin B, and dexamethasone (NPD) ophthalmic ointment.
Methods: A consecutive patient prospective study was performed. A total of 522 patients who had a procedure
involving incision of the periocular skin with subsequent postoperative application of NPD ophthalmic ointment
were included. Patients were evaluated for signs of allergy at 1 week postoperatively or prior if the patient had
complaints. A periocular allergic reaction was defined as any periocular skin pruritus, erythema, edematous papules,
vesicles, or plaques at the site of ointment application beyond that of the typical postprocedure presentation. The
patients continued to be monitored for 30 days postoperatively.
Results: Of the 522 patients who completed the study, eight (1.5%) had a definitive periocular allergic contact
dermatitis to the NPD ophthalmic ointment. Allergic presentation ranged from postoperative day 3 to 14.
Conclusions: The rate of periocular allergic reactions to NPD ophthalmic ointment is significantly lower than
reported in the literature for other topical preparations of neomycin and polymyxin B. The low rate of allergy
in this study suggests that NPD ophthalmic ointment can safely be applied to the periocular skin with a very
minimal risk of inciting an allergic reaction.
Background
An ophthalmic topical antibiotic is typically prescribed
as routine postoperative care for a variety of periocular
and ocular procedures [1, 2]. A commonly used oint-
ment consists of neomycin sulfate (3.5 mg, 1.2% concen-
tration), polymyxin B sulfate (10,000 units, less than
0.1% concentration), and dexamethasone (0.1%). In
addition, neomycin, polymyxin B, and dexamethasone
(NPD) ophthalmic ointment contains methylparaben
(0.05%) and propylparaben (0.01%), preservative agents
that provide antimicrobial activity and prevent biodeg-
radation of the compound. The ointment also contains
white petrolatum and anhydrous liquid lanolin, a carrier
vehicle and viscosity increasing agent used to enhance
bioavailability [3]. Furthermore, some NPD formulations
may contain mineral oil.
The use of NPD ointment is contraindicated if there is
known hypersensitivity to any component of the com-
pound [3]. Each of the agents in this combined steroid/
anti-infective ophthalmic ointment has been individually
investigated for the incidence of topical allergic contact
dermatitis—a type IV hypersensitivity reaction [4, 5].
Polymyxin B has a low sensitization rate, and there is
not sufficient evidence to discourage its use because
subsequent topical exposure to the antigen is unlikely to
cause an allergic contact dermatitis [6–8]. Conversely,
neomycin has been identified in the dermatologic litera-
ture as having high rates of sensitization due to previous
antigen exposure, thereby increasing the susceptibility
for an allergic contact dermatitis reaction with each suc-
cessive contact. Estimates regarding neomycin allergy
widely range in the literature [6–10]. For instance, the
prevalence of allergic contact reaction to neomycin
based on patch testing ranges from 1 to 6% [6–9]. Alter-
natively, Gehrig and Warshaw evaluated neomycin al-
lergy rates from the North American Contact Dermatitis
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Group (NACDG) and estimated that 7–13% of patients
were allergic to neomycin [10]. Several studies have con-
cluded that because of the frequency of sensitization and
risk of contact allergy upon re-exposure to the medica-
tion, neomycin-containing antibiotics should be avoided
in postoperative open and closed wound care [11, 12].
These findings have potentially resulted in reluctance by
surgeons to prescribe postprocedural topical neomycin
and/or combination ointments containing this agent.
NPD ointment is preserved with methylparaben
(0.05%) and propylparaben (0.01%). Parabens can trigger
irritation and allergic hypersensitivity reactions, but the
concentrations required (5–12%) are significantly higher
than what is used in clinical practice [4]. Few studies
examining parabens and ocular allergy are available in
the literature. The latest patch test results from the
NACDG revealed an allergy rate of 1.2% in the general
population at a paraben concentration of 12% [6]. In
addition, dexamethasone has been associated with a very
low rate of allergic contact skin reactions [5]. While
there are many different components within ophthalmic
ointments that patients may have an allergic contact re-
sponse to, most reactions appear to be secondary to
chemical irritation. Only 10% of reactions to all topical
ophthalmic medications are estimated to be the result of
a true allergic response [13, 14].
The incidence of allergic reaction to NPD or any other
steroid/anti-infective combination applied to the perio-
cular surface has not been well documented, and none
have investigated the postoperative use on open or
closed wounds. A report in 1976 showed the incidence
of periocular sensitivity reactions from a steroid/anti-in-
fective combination to account for one case per million
units (tube or bottle) of medication dispensed. Addition-
ally, they reported that the statistical incidence of adverse
reactions was no greater with the steroid/anti-infective
combination compared with the separate components
[15]. This and other reported studies are limited by retro-
spective analysis. In addition, most studies to date have
been performed on the trunk/extremity and often involve
a compromised cellular status such as seen in stasis
dermatitis, eczema, or leg ulcerations. Further complicat-
ing the evaluation of true incidence is the fact that studies
perform patch testing with a concentration far exceeding
the levels found in ophthalmic ointments. The purpose of
this study was to prospectively monitor the rate of perio-
cular allergic contact reactions to topical NPD ointment
following periocular surgical procedures in an attempt to
elucidate an accurate allergy rate.
Methods
The study was approved by the Mount Carmel Institutional
Review Board (IRB)/Ethics Committee prior to data collec-
tion. HIPPA compliance was maintained, and the study
adhered to the Declaration of Helsinki. Consecutive pa-
tients who had a procedure involving incision of the perio-
cular skin with subsequent postoperative application of
NPD ophthalmic ointment three times per day were in-
cluded in the study. Exclusion criteria included age less
than 18 years old; a reported history of allergy to neomycin,
polymyxin B, and compounds containing them; or usage of
intra- or postoperative systemic steroids. The physician
completed a data collection sheet for all patients at the 7-
day postoperative follow-up examination or prior if the
patient presented for evaluation. Data recorded included
patient age, sex, race, follow-up day, procedures performed,
allergic reactions to the ointment, use of intra- or postope-
rative systemic steroids, and administration of postoperative
oral antibiotics. An allergic reaction was defined as any
periocular skin pruritus, erythema, edematous papules, ve-
sicles, or plaques at the site of ointment application beyond
that of the typical postprocedure presentation [10]. The
patients continued to be monitored for 30 days postopera-
tive via self-surveillance with physician evaluation if a
suspected reaction was present. Patch testing was not con-
ducted in this study to confirm allergic reactions to the
NPD ointment.
Statistical analysis was performed using Prism v6.0
(Graphpad Software, Inc, La Jolla, CA). Analysis was
conducted at the 0.05 alpha level with two-tailed p values.
Fischer’s exact test was utilized to compare allergy rates
between males and females and those receiving oral anti-
biotics. An unpaired t test was used to compare age of
those with and without an allergic response. There was no
indication for the use of multiple comparison correction.
A priori power testing indicated a 95% power using the
above parameters and a 5% allergy rate at 140 patients.
Post hoc power analysis indicated the study achieved a
power of 99%.
Results
A total of 522 patients (female—329 (63%) (average age
64 ± 18 years)/male—193 (37%) (average age 56 ±
19 years)) with an average age of 61 years (range—14–
99 years, standard deviation ±19 years) were prospect-
ively monitored after application of NPD ointment. Of
these patients, eight (1.5%) patients (one male (13%),
seven females (87%); average age 57 ± 20 years, range
13–74 years) were documented as having a periocular al-
lergic reaction (Figs. 1 and 2). There was no significant
statistical difference between male and female allergy
rates (p = 0.268) or age of responders (p = 0.555). Aller-
gic response ranged from postoperative day 3 to 14. One
hundred eighty-seven patients (36%) were placed on sys-
temic oral antibiotics for 1 week following their proce-
dure. There was no significant statistical difference in
incidence of allergic reaction between those who did and
did not receive oral antibiotics (p = 0.142)
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Five of the patients (63%) who experienced an allergic
reaction had been prescribed postoperative oral anti-
biotics with no previous history of allergy or systemic
reaction. Seven of the eight patients’ (88%) allergic
symptoms improved once application of the NPD oint-
ment was discontinued. One patient required adminis-
tration of an oral steroid regimen to alleviate residual
allergic inflammation.
There were two patients who had indeterminate perio-
cular signs and symptoms of allergy at postoperative
evaluation and were not included in the reaction group.
One patient had swelling and itching, which was attri-
buted to an allergic rhinosinusitis. The other patient pre-
sented with redness and swelling that was deemed to be
a part of the expected postoperative response to surgery.
Both patients were continued on NPD ointment with
eventual resolution of their symptoms.
Discussion
In this study population, 1.5% of patients with postoper-
ative application of topical NPD ointment experienced a
periocular allergic contact skin reaction. Despite the
high rates of sensitization and allergy to neomycin re-
ported in the literature, the results confirmed our anec-
dotal observation of low allergy rates with NPD
ophthalmic ointment. In the study by Gehrig and War-
shaw, it is estimated that up to 13% of patients are
allergic to neomycin and at risk of experiencing an aller-
gic contact dermatitis [10]. However, reports of topical
allergic contact dermatitis from neomycin applied in
postoperative surgical patients revealed a lower rate ran-
ging from 4 to 5.3%, which more closely approximates the
periocular allergic rates observed in this study [11, 12, 16].
Based on the results of this study compared with the risk
estimates from previous reports, NPD ointment appears
to have a lower risk of causing allergic contact dermatitis
compared to other topical neomycin preparations.
In this study, there was no statistically significant age
or gender difference in allergy rates (p = 0.555 and 0.268,
respectively). de Pádua et al. conducted a retrospective
multifactorial analysis and concluded that patients older
than 60 years of age were 1.5 times more likely to have a
neomycin allergy [9, 17]. The average age of eight pa-
tients who experienced a periocular skin reaction in our
study was lower than those who had no reaction (57 ver-
sus 61 years). Furthermore, Nethercott et al. reported a
higher proportion of positive patch test results to neo-
mycin sulfate among females (p < 0.05) [18, 19]. In con-
cordance with our study population, seven of the eight
patients who experienced a contact dermatitis to NPD
ointment were female; however, this was not a statisti-
cally significant difference. Thus, NPD ointment does
not seem to have the same age- or gender-dependent
risk factors when compared to neomycin alone.
The non-antibiotic components of NPD ointment have
been shown to cause allergic hypersensitivity reactions,
but as previously discussed, the concentrations required
for this are 100 to 1000-fold greater to what is found in
the NPD compound studied [4, 6]. Similarly, dexametha-
sone has been associated with a very low rate of allergic
contact skin reactions [5]. While no conclusions can be
made regarding the reactivity of individual components
in NPD ointment, these findings support the low rate of
allergic contact reactions observed in this study.
We recognize that this study is not without limitations;
however, the prospective nature serves to minimize them.
This study is at risk for observer bias as each of the par-
ticipating physicians was aware that patients received
NPD ointment. This may have influenced the decision to
record an observed response as a normal postoperative
reaction secondary to surgery as opposed to an allergic re-
action to the ointment. A standardized data collection
Fig. 1 Patient on postoperative day 7 following left ectropion repair.
The patient displays an allergic reaction to the NPD ointment that
he applied two to three times a day to the upper and lower eyelid
on the left
Fig. 2 Patient on postoperative day 7 following bilateral lower eyelid
entropion repair. This patient illustrates an allergic reaction to the NPD
ointment that she applied two to three times a day. This particular patient
was also instructed to apply ointment onto the ocular surface for dryness
causing a conjunctival reaction to the NPD that can be seen in the form
of conjunctival edema and hyperemia
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sheet was created in attempt to obtain a uniformed assess-
ment from each physician to limit this bias. We also
recognize that many dermatologic studies evaluated each
entity of the NPD ointment individually. There is the po-
tential that our low rate of periocular reactions could be
secondary to a steroid suppression effect from the dexa-
methasone within the ointment—though one study re-
ported no difference in allergic reactions between steroid/
anti-infective combinations and each component indivi-
dually [15]. Patch testing was not performed on any of the
patients diagnosed with an allergic reaction to the NPD as
the clinical evidence was sufficient to make the diagnosis.
Due to the large sample size, we would expect patch tes-
ting to cause a false elevation of the clinically identifiable
allergy reactions, not a reduced incidence.
Conclusions
Based on the results of this prospective study, postopera-
tive application of NPD ointment to the periocular skin
has a low risk of causing an allergic reaction in patients
with no history of allergy. Surgeons should not avoid
NPD ointment in the postoperative setting for periocular
surgery based upon the low allergic rate demonstrated. Fu-
ture studies are needed to evaluate the periocular reactions
experienced with application of individual topical anti-
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